Maxim Group analyst Jason McCarthy assigned a Buy rating to VolitionRX (VNRX – Research Report) yesterday and set a price
Tag: Jason McCarthy
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biocept (BIOC
Omeros (OMER) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy assigned a Buy rating to Omeros (OMER – Research Report) yesterday and set a price
Analysts Offer Insights on Healthcare Companies: Galapagos (NASDAQ: GLPG) and InflaRx (NASDAQ: IFRX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG –
Maxim Group Issues a Buy Rating on Coherus Biosciences (CHRS)
In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Coherus Biosciences (CHRS – Research
Diamedica Therapeutics (DMAC) Initiated with a Buy at Maxim Group
Diamedica Therapeutics (DMAC – Research Report) received a Buy rating and a $14.00 price target from Maxim Group analyst Jason
TRACON Pharmaceuticals (TCON) Received its Third Buy in a Row
After BTIG and H.C. Wainwright gave TRACON Pharmaceuticals (NASDAQ: TCON) a Buy rating last month, the company received another Buy,